Price $119.78 |
Market Cap
215.38B
|
Sector Health Care |
Div. Growth
12.50%
|
|
P/E
47.6
|
P/B
6.49
|
P/S
6.15
|
Dividend %
1.50%
|
|
P/CF
72.0
|
P/FCF
67.8
|
Op. Cash Flow
7.9M
|
FCF
1.7
|
|
Op. Margin
15.80%
|
Net Margin
13.00%
|
ROE
14.40%
|
ROI
9.70%
|
|
ROA
6.50%
|
EPS Growth
21.50%
|
Current Ratio
1.7
|
Debt/Equity
56.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| AngioDynamics, Inc. (ANGO) | $20.95 | - | - | 776.4M | Strong Buy |
| Cara Therapeutics Inc (CARA) | $18.93 | - | - | 959.8M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $10.92 | - | - | 12.34B | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.73 | - | - | 62.5M | Strong Buy |
| Sonoma Pharmaceuticals Inc (SNOA) | $7.90 | - | - | 17.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
